Are you a qualified physiotherapist working in oncology? Or perhaps a qualified level 3 personal trainer?
20 August, 2019
GenesisCare have many exciting opportunities... At GenesisCare we prescribe exercise as an integral part of our cancer care. Before, during and after patients treatment. Doctors used to think that rest was the right answer. However, research shows that staying active can improve long term cancer survival rates and can also reduce the risk of the…
8 August, 2019
‘Outstanding’ Care Quality Commission rating for GenesisCare’s Maidstone centre
GenesisCare has been awarded an overall Outstanding rating for its highly individualised and effective cancer patient care and treatment The inspectors noted that patients were offered excellent personalised care and emotional support including complementary therapy and relaxation sessions The CQC rating also identified the exceptional staff at GenesisCare in Maidstone We are really pleased to…
25 July, 2019
Cancer patients in the Midlands are set to benefit from a new collaboration between specialist prostate treatment group Birmingham Prostate Clinic (BPC), and the UK’s largest cancer care provider, GenesisCare. BPC will become part of GenesisCare, in a move to increase patient access to GenesisCare’s leading prostate cancer therapies, including advanced diagnostics and a ground-breaking,…
19 July, 2019
Cancer patients will have rapid access to pioneering technology, with a new MR Linac capable of targeting tumours more precisely from spring 2020 The service will be the first of its kind in London outside of a research study GenesisCare’s investment over the next year will also bring a wide range of high-end technology and…
3 June, 2019
Theranostics: New hope for late stage prostate cancer patients with an innovative UK-first treatment
Theranostics is a personalised cancer treatment that combines diagnostics and therapy to detect and treat late stage prostate cancer and neuroendocrine tumours. GenesisCare Windsor is the first centre in the UK to make 177Lutetium PSMA, a personalised therapy for patients with advanced prostate cancer, clinically available. Windsor, UK, 3 June 2019 – The first patients…
16 May, 2019
SpaceOAR® Hydrogel as part of our standard pre-radiotherapy treatment.
We believe patients deserve the best and that’s why we offer SpaceOAR® Hydrogel as part of our standard pre-radiotherapy treatment. We design our care to help give patients the best possible life outcomes. Which is why since January 2018 we’ve successfully delivered 200 SpaceOAR® Hydrogel insertions as part of our standard pre radiotherapy treatment for…
9 May, 2019
New look at GenesisCare centres. We are excited to share that we’ve started the installation of a fresh new look at our UK centres. So far 6 of our centres have had the new signage installed and plans are in place to complete the other 6. The new signage makes it easier for patients to…
11 March, 2019
GenesisCare, the largest private provider of cancer and cardiac healthcare in Australia and Europe, announced today that KKR’s investment in the Company had successfully completed. The transaction was originally announced in October 2018. Since that time, the transaction has received approval from GenesisCare shareholders and regulatory clearance from relevant authorities in Australia, Europe and China….
7 February, 2019
GenesisCare and the University of Oxford establish innovative 10-year research partnership
GenesisCare and the University of Oxford establish innovative 10-year research partnership to improve diagnosis and care for people with cancer 10-year partnership established between the UK’s largest private provider of radiotherapy and world-leading university to drive cancer research and improve care services across the UK Major investment will bring advanced radiotherapy technology to the UK…
20 December, 2018
Karthik is a Consultant Haematologist at Oxford University Hospitals NHS Trust and GenesisCare’s new Clinical Director for haematology services. Karthik is also the Director of the Oxford Myeloma Translational Research Centre, the Lead Clinician for myeloma and other plasma cell dyscrasias at the Thames Valley Strategic Clinical Network, Divisional Lead for Cancer research for National…
